Skip to main content
Clinical Trials/NCT03742310
NCT03742310
Unknown
Not Applicable

Multi-Center Clinical Study on the Relationship Between Vitamin D Receptor Gene Polymorphism and Children's Physical and Intellectual Development

First Affiliated Hospital Xi'an Jiaotong University1 site in 1 country500 target enrollmentJanuary 1, 2019
InterventionsVitamin D

Overview

Phase
Not Applicable
Intervention
Vitamin D
Conditions
Development, Child
Sponsor
First Affiliated Hospital Xi'an Jiaotong University
Enrollment
500
Locations
1
Primary Endpoint
body weight
Last Updated
7 years ago

Overview

Brief Summary

This study was used to determine the relationship between vitamin D receptor gene polymorphism and children's physical and intellectual development, further adjust the doses of vitamin D supplementation after birth, and provide individualized vitamin D and calcium supplements.

Detailed Description

High risk children aged 0-3 years old who visited the pediatrics clinic and ward of the first affiliated hospital of Xi'an Jiaotong university and other cooperative hospitals from 2018 to 2020 were randomly selected. Personal information of the children and parents who were enrollment was collected by questionnaire survey and a follow-up file was established. 500 to 1,000 people are planned to participate in the study, were randomly divided into research group and the control group. Then collect the sample(saliva) of children to examine Vitamin D Receptor(VDR) genotype, according to results, divide the research group into high, medium and low risk, given individual vitamin D and calcium supplement. Monitor the children's weight, body length, head circumference, the Neonatal Behavioral Assessment Scale(NBAS), bailey rating scale respectively, up to 3 years old. All sample analyses were performed by the Gene Medical Laboratory. Laboratory personnel were blinded to mother and infant outcomes.

Registry
clinicaltrials.gov
Start Date
January 1, 2019
End Date
March 1, 2021
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • infant age from 0 to 3 years old
  • enjoy good health, there is no history of specific diseases

Exclusion Criteria

  • this time or always exists serious lung infection, or with nervous system disease, kidney disease, malignant tumor, etc
  • has bone metabolic diseases or other genetic metabolic disease
  • taking affect bone metabolism of drugs for a long time

Arms & Interventions

identical supplement group

Take vitamin D supplements according to genotype. If the genotype result is "high risk", we will give vitamin d 800 international unit(IU)/d, when the result is "middle risk", we will give 600 international unit(IU)/d, when the result is "low risk", we will give 400 international unit(IU)/d.

Intervention: Vitamin D

Outcomes

Primary Outcomes

body weight

Time Frame: From date of randomization until the date of three year-old

We will use the baby scale to measure infant body weight

body height

Time Frame: From date of randomization until the date of three year-old

We will use the baby scale to measure infant body height

head circumference

Time Frame: From date of randomization until the date of three year-old

We will use the tape to measure infant head circumference

Study Sites (1)

Loading locations...

Similar Trials